The first phase rapid insulin response is impaired in hyperglycaemic T2DM patients [5,36], and may be a significant T2DM risk marker for hyperinsulinaemic/normoglycaemic people (phenotype 3, stage 1) [127]. The gene discussed is INS; the disease is type 2 diabetes mellitus.